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Abstract 
Corynantheine alkaloids with a tetracyclic indole[2,3-a]-quinolizidine motif are an important 
issue in academia and in the life science industries due to their broad bioactivity profile ranging 
from antiarthritic, analgesic, anti-inflammatory, antiallergic, antibacterial, to antiviral activities. 
For that reason, in the last decades, numerous efforts have been invested in the development of 
novel synthetic strategies to obtain the indole[2,3-a]-quinolizidine system. This review focuses 
on the synthetic methodologies developed to target the most important alkaloids of this family, 
and highlights the potential use of these alkaloids or analogs to treat several diseases, ranging 
from cancer to neurodegenerative disorders. 
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Introduction 
Corynantheine alkaloids with a tetracyclic indole[2,3-a]-quinolizidine motif are of great interest 
for academia and pharmaceutical companies due to their broad bioactivity profile. In fact, this 
type of indole alkaloids have been described with different biological activities, ranging from 
antiarthritic, analgesic, anti-inflammatory, to anti-cancer activities. For this reason, in the last 
decades, numerous efforts have been invested in the development of novel synthetic strategies 
to obtain the indolo[2,3-a]quinolizidine system present in numerous monoterpenoid-derived 
alkaloids.[1-3] Since the chirality of the corynantheine alkaloids is crucial for the expression of 
bioactivity, there is a huge interest in the development of new enantioselective synthesis to 
obtain indolo[2,3-a]quinolizidine alkaloids. In particular, several research studies (development 
of novel synthetic strategies and biological evaluation) have been conducted with corynantheine 
alkaloids, such as dihydrocorynantheine (1), corynantheine (2), dihydrocorynantheol (3), 
hirsutine (4), hirsuteine (5), and geissoschizine methyl ether (6) (Figure 1). This review focus on 
the pharmacological and therapeutic interest of indolo[2,3-a]quinolizidines and the most recent 
advances in asymmetric synthetic strategies to obtain the main skeleton of these indole 
alkaloids. All the papers described in this review were found using Scifinder, PubMed, and Web 
of Science databases.  
  
 
Figure 1 – Examples of corynantheine alkaloids. 
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1. Biological activities of indolo[2,3-a]quinolizidine alkaloids 
 
1.1 Arborescidine A and desbromoarborescidine A 
In 1966, it was described the isolation of 1,2,3,4,6,7-hexahydro-12H-indolo[2,3-a]quinolizine 
alkaloid (latter called desbromoarborescidine A) from Dracontomelum mangiferum.[4] The 
cardiovascular activities of desbromoarborescidine A (7) and five natural product analogs 8-12 
(Figure 2) were evaluated by studying the effect of these alkaloids in blocking Alpha-1 and 
Alpha-2 adrenoceptors. Desbromoarborescidine A (7) showed a strong blocking activity of the 
adrenoceptors compared with the other 5 alkaloids. In fact, the presence of a hydroxyl group at 
position 1 led to loss of activity.[5] 
In 1993, it was described the isolation of the brominated indole alkaloid arborescidine A (13) 
from the marine tunicate Pseudodistoma arborescens.[6] The antiproliferative activity of 
desbromoarborescidine A (7) and arborescidine A (13) (Figure 2) was evaluated in vitro against 
several tumor cell lines (lung fibroblasts, gastric adenocarcinoma, leukemia and others). 
Arborescidine A (13) showed an IC50 value of 34.5 µM for leukemia, while 
desbromoarborescidine A (7) was weakly active in all tumor cell lines tested (IC50 higher than 
50 µM).[7]  
  
 
Figure 2 – Chemical structure of desbromoarborescidine A (7), indoloquinolizidines 8-12, and 
arborescidine A (13). 
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1.2 Dihydrocorynantheine (1), corynantheine (2), and derivatives  
In the late 80’s Chang et al. reported the effects of dihydrocorynantheine (1) (see Figure 1) in 
arterial pressure. The alkaloid was extracted from the dried leaves and stems of Uncaria 
Callophylla and the studies demonstrated that dihydrocorynantheine (1) can effectively lower 
the arterial pressure in both anaesthetized and conscious normotensive rats.[8] 
Later, Masumiya et al. described that dihydrocorynantheine (1) showed direct effects on the 
potential action of cardiac muscle through inhibition of multiple ion channels, which could 
explain their negative chronotropic and antiarrhythmic activity.[9] 
In 2000, dihydrocorynantheine (1), corynantheine (2), and corynantheidine (14) were isolated 
from bark of Corynanthe pachyceras K. Schum. (Rubiaceae). These alkaloids, and two 
corynantheidine racemic synthetic derivatives 15-16 (Figure 3), were tested against Leishmania 
major promastigotes. All compounds were active for Leishmania, presenting IC50 values 
between 0.7 and 2.8 µM. The three alkaloids were also evaluated for antiplasmodial and 
cytotoxic activities but revealed to be inactive.[10] 
 
 
Figure 3 – Chemical structure of corynantheidine (14) and two synthetic derivatives 15-16. 
 
1.3 Dihydrocorynantheol (3) and derivatives 
In 2011, Fröde’s research group reported for the first time the anti-inflammatory effects of 
dihydrocorynantheol (3) (see Figure 1), an alkaloid isolated from Esenbeckia leiocarpa. 
Dihydrocorynantheol (DHC) (3) was shown to play a pivotal role in the anti-inflammatory 
effect exercised by this herb by preventing the IκB α ubiquitination and consequent degradation, 
inhibiting thus the NF-κB cascade and, consequently, the production of several pro-
inflammatory mediators, such as IL-1β and TNF-α.[11]  
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A series of ester dihydrocorynantheol derivatives (DHC-acetyl 17, DHC-p-methylbenzoyl 18, 
DHC-benzoyl 19, DHC-p-methoxybenzoyl 20 and DHC-p-chlorobenzoyl 21) (Figure 4) were 
also tested as anti-inflammatory agents. It was observed that protection of the hydroxyl group 
resulted in a decrease of activity, which indicates that the presence of a hydroxyl group in the 
chemical structure of dihydrocorynantheol (3) is important for the activity of this alkaloid 
against inflammation.[12] 
 
Figure 4 - Chemical structure of dihydrocorynantheol (3) and indoloquinolizidines 17-21. 
 
1.4 Hirsutine (4), hirsuteine (5), geissoschizine methyl ether (6) and derivatives 
Hirsutine (4), hirsuteine (5) and geissoschizine methyl ether (6) (see Figure 1) are the primary 
constituents of Uncaria sp. Hirsutine (4), isolated from Uncaria rhynchophylla (traditional 
Chinese herb medicine), was described to possess antihypertensive and antiarrhythmic activities 
through modulation of the intracellular Ca
2+
 levels in rat thoracic aorta[13] and action potential 
in cardiac muscle[9]. Moreover, hirsutine (4) was shown to be effective in the protection of rat 
cardiomyocytes from hypoxia-induced cell death.[14] Moreover, the effects of hirsutine (4), 
hirsuteine (5) and geissoschizine methyl ether (6) (Figure 1), extracted from Uncariae Ramulus 
et Uncus, were evaluated on vascular responses. Geissoschizine methyl ether (6) proved to be 
14 times more active (EC50 = 0.744µM) than hirsutine (4), in norepinephrine-induced 
vasocontractive response. Also, geissoschizine methyl ether (6) was shown to have two 
different mechanisms of action: endothelium dependency with nitric oxide and endothelium 
independency with voltage-dependent Ca
2+
 - channel blocking. Therefore, geissoschizine 
methyl ether (6) might be a candidate for vasodilative or antihypertensive medicines.[15]  
In 2011, villocarine A (Figure 5) was isolated from the leaves of Uncaria villosa (Rubiaceae). 
In that report, the authors describe villocarine A as a new indole alkaloid, however the structure 
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is identical to the indole alkaloid 3-epi-geissoschizine methyl ether (22). Villocarine A showed 
potent vasorelaxant effects at 30 µM in rat aortic ring assays, revealed some inhibition effect on 
vasocontraction of depolarized aorta with high concentration potassium, and showed inhibition 
effect on phenylephrine (PE)-induced contraction in the presence of nicardipine in a Ca
2+
 
concentration-dependent manner.[16, 17]  
In 2011, T. Ueda et al. demonstrated that geissoschizine methyl ether (6) is a partial agonist at 
the serotonin 5-HT1A receptor, a partial agonist/antagonist at the dopamine D2L receptor and an 
antagonist at the serotonin 5-HT2A, 5-HT2C and 5-HT7 receptors. The pharmacological profiles 
of geissoschizine methyl ether (6) were similar to aripiprazole (commercial drug used for the 
treatment of schizophrenia and related disorders), however, geissoschizine methyl ether (6) was 
less potent than aripiprazole at dopamine D2L receptors (EC50=4.4 μM for geissoschizine methyl 
ether (6) vs. EC50=56 nM for aripiprazole).[18] Moreover, in 2012, gissoschizine methyl ether 
(6) was described as a potential acetylcholinesterase inhibitor. In this study, hirsutine (4), 
hirsuteine (5), and vallesiachotamine (23) (Figure 5), extracted from the hooks of Uncaria 
Rhynchophylla, were also tested. The results showed an inhibition of 50% of 
acetylcholinesterase activity at concentrations of 3.7±0.3 μg mL-1 for geissoschizine methyl 
ether (6). Hirsutine (4), hirsuteine (5), and vallesiachotamine (23) were weakly active against 
acetylcholinesterase.[19] Moreover, turbinatine (24) (Figure 5),[20] a corynanthean-type indole 
alkaloid, with a similar structure with geissoschizine methyl ether (6), inhibited 
acetylcholinesterase with an IC50 of 0.99 μg mL
-1
.[19]  
The efficacy of hirsutine (4) on neuroinflammation control was also explored. It was shown that 
hirsutine (4) reduces the production of several neurotoxic factors in activated microglial cells 
and possesses neuroprotective activity in a model of inflammation-induced neurotoxicity. In 
particular, in organotypic hippocampal slice cultures, hirsutine (4) blocked lipopolysaccharide-
related hippocampal cell death and production of nitric oxide, prostaglandin E2 and interleukin-
1β.[21] 
In 2014, a new alkaloid, 4-geissoschizine N-oxide methyl (25) (Figure 5), was isolated from the 
hook-bearing branch of Uncaria rhynchophylla. The neuroprotective effects of this compound, 
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and 5 other alkaloids [hirsutine (4), hirsuteine (5), 4-hirsuteine N-oxide (26), geissoschizine 
methyl ether (6), 3-epi-geissoschizine methyl ether (22)] were evaluated against 3mM 
glutamate-induced HT22 cell death. The 4-geissoschizine N-oxide methyl ether (25) and 4-
hirsuteine N-oxide (26) compounds revealed to be weak neuroprotective agents. On the other 
hand, the remaining compounds showed potent neuroprotective effects against glutamate 
induced HT22 cell death.[22] 
 
 
Figure 5 – Chemical structure of 3-epi-geissoschizine methyl ether (22), vallesiachotamine (23), 
turbinatine (24), 4-geissoschizine N-oxide methyl ether (25), 4-hirsuteine N-oxide (26). 
 
Hirsutine (4) was also identified as an anti-metastatic by targeting nuclear factor-kB activation 
from a screening of 56 natural product derivatives. In particular, hirsutine (4) strongly 
suppressed NF-kB activity in murine 4T1 breast cancer cells, reducing the metastatic potential 
of 4T1 cells. Moreover, hirsutine (4) reduced the in vivo lung metastatic potential of 4T1 cells. 
These results indicate that hirsutine (4) can be an attractive lead compound for reducing the 
metastasis potential of cancer cells.[23]  
 
 
1.5 Arboricinine and arboricine 
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Arboricinine (27) and arboricine (28) (Figure 6) were isolated from stem-bark extract of the 
Malayan Kopsia arborea. These indoloquinolizidines revealed moderate cytotoxicity against 
KB/VJ300 cell lines, a vincristine-resistant human oral epidermoid carcinoma, with IC50 values 
around 30 µM.[24] 
 
Figure 6 – Chemical structure of arboricinine (27) and arboricine (28). 
 
1.6 Vallesiachotamine 
In 1981, Z-vallesiachotamine (29) (Figure 7), a monoterpene indole alkaloid, isolated from 
Rhaza stricta, was reported to have anticancer properties on a carcinoma cell line.[25] Latter, 
the in vitro antiproliferative activity of vallesiachotamine isolated from the leaves of Policourea 
rigida was investigated on human melanoma cells. The compound presented an IC50 value of 
14.7 µM in SK-MEL-37 melanoma cells (two times more active than doxorubicin), induced 
accumulation of melanoma cells in the G0/G1 growth phase and increased the proportion of 
sub-G1 hypodiploid cells (at 11 µM and 22 µM). Moreover, at 50 µM, vallesiachotamine 
caused extensive cytotoxicity and necrosis.[26]  
Vallesiachotamine was also tested for therapeutic targets involved in neurodegeneration. In 
particular, extracts obtained from Psychotria laciniata containing Z-vallesiachotamine (29), and 
E-vallesiachotamine (30) (Figure 7) as major compounds, showed high potency against 
monoamine oxidase A (MAO-A) and only moderate potency against monoamine oxidase B 
(MAO-B).[27] Moreover, Z-vallesiachotamine (29), E-vallesiachotamine (30), and 
vallesiachotamine lactone (31) (Figure 7) were shown to inhibit butyrylcholinesterase (BChE) 
and MAO-A with IC50 values ranging from 7.08 to 14 µM for BChE inhibition and from 0.85 to 
2.14 µM for MAO-A inhibition.[28] Finally, using a computational structure-based approach, it 
was investigated if these three alkaloids bind sirtuin 1 and sirtuin 2. The compounds 
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demonstrated a SIRT1 inhibitory profile comparable to that of sirtinol (nonspecific SIRT 
inhibitor). Opposite to Z-vallesiachotamine (29) and E-vallesiachotamine (30), 
vallesiachotamine lactone (31) demonstrated no apparent toxicity on Hek 293 and on rat 
astrocyte primary cells.[29] These findings are in line with the study of Z-vallesiachotamine 
(29) on human melanoma cells.[26] 
 
 
Figure 7 – Chemical structure of Z-vallesiachotamine (29), E-vallesiachotamine (30), and 
vallesiachotamine lactone (31). 
 
1.7 Mitragynine and derivatives 
In 2005, Matsumoto et al. have studied the effect of mitragynine (32) (Figure 8), a major indole-
alkaloid founded in Thai medicinal herb Mitragyna speciosa, on neurogenic contraction of 
smooth muscle. The results demonstrated that mitragynine (32) inhibited the contraction of 
guinea-pig vas deferens produced by electrical transmural stimulation. More precisely, 
mitragynine (32) was found to block T- and L-type Ca
2+
 channel currents and reduced KCl-
induced Ca
2+
 influx in N1E-115 neuroblastoma cells.[30]  
One year later, 7-hydroxyspeciociliatine (33) (Figure 8) was isolated, for the first time, from the 
fruits of Malaysian Mitragyna speciosa Korth. The opioid agonistic activity of this alkaloid and 
7-hydroxymitragynine (34) was investigated in guinea-pig ileum experiments. The results 
demonstrated that 7-hydroxyspeciociliatine (33) had a weak stimulatory effect on µ-opioid 
receptors,[31] while 7-hydroxymitragynine (34) had moderate opioid agonist activity, as 
reported previously.[32, 33]  
Also, 9-demethyl analogue of mitragynine, 9-hydroxycorynantheidine (35) (Figure 8), 
synthesized from mitragynine, was reported as a partial agonist of opioid receptors. The 
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receptor binding assays revealed that 9-hydroxycorynantheidine (35) has affinity for three 
opioid receptor types. In particular, 9-hydroxycorynantheidine (35) (Figure 8) presented pKi 
values of 7.92, 4.51 and 5.53, for µ-, δ- and κ-opioid receptors, respectively. The results show 
that 9-hydroxycorynantheidine (35) has a high affinity and selectivity for µ-opioid 
receptors.[34]  
Also, recently Shamima et al. investigated the action of mitragynine (32) as antinociceptive 
agent. The goal of this study was to understand if mitragynine (32) acts on Cannabinoid 
receptor type 1. The results demonstrated that mitragynine (32) doesn’t act on Cannabinoid 
receptor type 1 but through activation of opioid receptor system, more precisely on μ- and δ-
opioid receptors.[35] 
More recently, two derivatives of 7-hydroxymitragynine (compounds 36 and 37, Figure 8), were 
synthesized in order to develop dual-acting μ- and δ-opioid agonists. Compound 37 was shown 
to be more potent, in vitro and in vivo, than compound 36 and 7-hydroxymitragynine (34). 
Compound 37 exhibited a high affinity for μ- and δ-opioid receptors, with Ki values of 2.1 and 
7.0 nM, respectively, while compound 36 reveled Ki values of 6.4 nM (μ-opioid receptor) and 
16.0 nM (δ-opioid receptor). Moreover, the antinociceptive effect of compound 37 was 
approximately 240 times more potent than that of morphine in a mouse tail-flick test and, for 
this reason compound 37 could be used as potential therapeutic agent for treating neuropathic 
pain.[36] 
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Figure 8 – Chemical structure of mitragynine (32), 7-hydroxyspeciociliatine (33), 7-
hydroxymitragynine (34), 9-hydroxycorynantheidine (35) and indoloquinolizidines 36-37. 
 
1.8 Non-natural indolo[2,3-a]quinolizidine derivatives 
Takanawa et al., reported the synthesis of 10 mitragynine derivatives in order to perform a 
structure-activity relationship study. The rational was based on the fact that mitragynine (32) 
has analgesic activity. The effects of corynantheidine (14) (Figure 3), mitragynine (32) (Figure 
8), synthetic derivatives 35, 38-46, and speciociliatine (47) (Figure 9) were evaluated on opioid 
receptors, using electrically stimulated contraction in isolated guinea pig ileum. Seven 
compounds (compounds 32, 35, 42-43, and 45-47) revealed an interesting potency against 
opioid receptors (Graph 1).  
 
Figure 9 – Chemical structure of mitragynine derivatives 38-46 and speciociliatine (47). 
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The potency of mitragynine (32) revealed to be one-fourth of morphine (standard compound 
that has a relative potency of 100%). The 9-demethoxy analogue of mitragynine, i.e. 
corynantheidine (14), did not show any opioid agonistic activity. However, analysis of its 
effects on twitch contraction inhibited by morphine, atropine, and verapamil in electrically 
stimulated guinea pig ileum, showed that corynantheidine (14) inhibits the effect of morphine 
via functional antagonism of opioid receptors. On the other hand, 9-hydroxycorynantheidine 
(35) inhibited electrically induced twitch contraction in guinea pig ileum and revealed relative 
potency higher than mitragynine (32). The introduction of the acetoxy group on the indole ring 
(compound 42), led to marked reduction in both intrinsic activity and potency as compared with 
those of mitragynine (32) (Graph 1). Mitragynine derivative 41 did not show any opioid agonist 
activity, which indicates that the functional groups at the C9 position are very important for the 
activity of these compounds. 
Speciociliatine (47), a C-3 stereoisomer of mitragynine (32), could be found as a minor 
constituent on Mitragyna speciosa. This compound reveled to be 14-fold weaker than 
mitragynine (32). The introduction of a methoxy or an ethoxy group at the C-7 position, 
respectively, compounds 45 and 46, led to a dramatic reduction in potency for opioid receptors 
and, which indicates that the hydrogen atom at the C-7 position in mitragynine (32) has an 
important role for the activity. Finally, compound 44, showed a relative potency 13- and 46-fold 
higher for opioid receptors than those of derivative 39 and mitragynine (32), respectively. 
Compound 44 demonstrated affinity also for δ- and κ-receptors. 
The relative affinities of compounds 14, 32, 35 and 44, for the three opioid receptors (µ, δ and 
κ), were determined using receptor binding assay (Graph 2) using morphine as comparison 
standard. The results show that these compounds have relatively high selectivity for µ-receptors. 
Moreover, mitragynine (32) revealed some affinity for δ-receptor, while compound 44 
demonstrated affinity for both δ- and κ-receptors.[37]  
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Graph 1 - Relative potency of seven compounds with interesting activities for opioid receptor. 
 
 
 
Graph 2 - Relative affinity of indoloquinolizidines 14, 32, 35, 44 for µ, δ, and κ receptor types. 
 
Waldmann et al. evaluated a collection of approximately 11000 natural-product derived and 
inspired compounds as apoptosis inducers. From that library, seven indoloquinolizidine 
derivatives 48-54 (Figure 10) were considered potential apoptosis inducers in three human 
tumor cell lines, presenting values of IC50 around 2 µmol L
-1
 in HeLa (cervix), MCF-7 (breast) 
cell lines and in HepG2 (liver, with slightly lower efficiency) cell lines.[38]  
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Figure 10 - Chemical structure of indoloquinolizidine derivatives 48-54. 
 
A series of 20 indolo[2,3-a]quinolizidine-peptide hybrids was synthesized and evaluated for D1 
dopamine receptors (D1R) and D2 dopamine receptors (D2R). Two diastereomeric indolo[2,3-
a]quinolizidines were coupled with tripeptides in order to enhance the affinity of the 
indoloquinolizidine moiety for the dopamine receptors. Several compounds presented higher 
affinities than dopamine. Furthermore, it was shown that trans (C-3 and C-12b) 
indoloquinolizidine derivatives had stronger effect in the interaction with the receptors than cis 
indoloquinolizidine derivatives (Figure 11).[39] The functional characterization of the hybrid 
compound 61 by means of kinetic assays and competition experiments in radioligand binding, 
demonstrated that indoloquinolizidine-peptide 61 behaves as an orthosteric ligand of dopamine 
D2, D3, D4 and D5 receptors, but as a negative allosteric modulator of agonist and antagonist 
binding to striatal dopamine D1 receptors. In addition, compound 61 decreased receptor 
potency, while preserving agonist-induced maximal cAMP production.[40]  
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Figure 11 – Most active indoloquinolizidine-peptide hybrids. 
 
In 2015, a novel indoloquinolizidine derivative 62 (Figure 12) was synthesized and evaluated as 
an anti-hypertension agent. The compound showed remarkable antihypertensive and dilating 
effect both in vitro and in vivo. Moreover, it was shown that compound 62 induced 
vasodilatation by both endothelium-dependent and-independent manners, blocked Ca
2+
 influx 
through L-type Ca
2+
 channels and inhibited intracellular Ca
2+
 release while not affecting K
+
 
channel.[41] 
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Figure 12 – Chemical structure of indoloquinolizidine derivative 62. 
 
In tables 1 and 2 the reader can find a summary of the main biological properties described to 
date for Indolo[2,3-a]quinolizidines and derivatives. 
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Table 1 – Biological properties of Indolo[2,3-a]quinolizidines and derivatives. 
Compound Species isolated from Effects Refs 
 
UncariaCallophylla 
 
Corynanthepachyceras 
- lowers the arterial pressure in both anaesthetized and conscious normotensive rats 
- inhibition of multiple ion channels 
- active for Leishmania 
[8-10] 
 
 
 
Corynanthepachyceras - active for Leishmania [10] 
 
Esenbeckialeiocarpa - anti-inflammatory effects [11] 
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Uncaria rhynchophylla - antihypertensive and antiarrhythmic activities 
- reduces the production of several neurotoxic factors in activated microglial cells and 
possesses neuroprotective activity in a model of inflammation-induced neurotoxicity 
- potent neuroprotective effects against glutamate induced HT22 cell death 
anti-metastatic 
[9, 13-14, 
21-23] 
 
 - potent neuroprotective effects against glutamate induced HT22 cell death [22] 
 
Uncariae Ramulus et 
Uncus 
- Active in norepinephrine-induced vasocontractive response 
partial agonist at the serotonin 5-HT1A receptor, a partial agonist/antagonist at the 
dopamine D2L receptor and an antagonist at the serotonin 5-HT2A, 5-HT2C and 5-
HT7 receptors 
- potential acetylcholinesterase inhibitor 
- potent neuroprotective effects against glutamate induced HT22 cell death 
[15, 18-19, 
22] 
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Corynanthepachyceras - active for Leishmania 
- affinity for opioid receptors 
[10, 37] 
 
Dracontomelum 
mangiferum 
- blocking of Alpha-1 and Alpha-2 adrenoceptors 
 
[5] 
 
Pseudodistoma arborescens - IC50 value of 34.5 µM for leukemia [6-7] 
 
Uncaria villosa - potent vasorelaxant effects at 30 µM in rat aortic ring assays 
- potent neuroprotective effects against glutamate induced HT22 cell death 
[16-17, 22] 
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Uncaria rhynchophylla - acetylcholinesterase inhibitor [19] 
 
Malayan Kopsiaarborea - moderate cytotoxicity against KB/VJ300 cell lines (IC50 values around 30 µM) [24] 
 
Malayan Kopsiaarborea - moderate cytotoxicity against KB/VJ300 cell lines (IC50 values around 30 µM) [24] 
 
Rhazastricta 
 
Policourearigida 
- anticancer properties on a carcinoma cell line 
- inhibit butyrylcholinesterase (BChE) 
Mixture of isomers Z and E: 
- IC50 value of 14.7 µM in SK-MEL-37 melanoma cells 
- high potency againstmonoamine oxidase A (MAO-A) 
[25, 28] 
 
[26-27-28] 
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Psychotrialaciniata - inhibit butyrylcholinesterase (BChE) [28] 
 
Mitragynaspeciosa - analgesic activity in N1E-115 neuroblastoma cells [30, 37] 
 
Mitragynaspeciosa - moderate opioid agonist activity [32, 33] 
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Table 2 – Biological properties of Indolo[2,3-a]quinolizidine derivatives. 
 
Compound Effects Refs 
 
- partial agonist of opioid receptors, high affinity and selectivity for µ-opioid receptors [34] 
 
- high affinity for μ- and δ-opioid receptors [36] 
 
- affinity for opioid receptors [37] 
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- affinity for opioid receptors [37] 
 
- potential apoptosis inducers in three human tumor cell lines (HeLa, MCF-7 and HepG2 cell 
lines) 
[38] 
 
- orthosteric ligand of dopamine D2, D3, D4 and D5 receptors; negative allosteric modulator of 
agonist and antagonist binding to striatal dopamine D1 receptors. 
[39-40] 
 
- blocked Ca
2+
 influx through L-type Ca
2+
 channels and inhibited intracellular Ca
2+
 release [41] 
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2 Synthesis of indolo[2,3-a]quinolizidine alkaloids 
The aim of this part of the review is to present the state of the art of the different strategies 
developed in enantioselective indolo[2,3-a]quinolizidine alkaloid synthesis, illustrated with 
representative examples. It is divided in three sections, namely, use of chiral pool resources, 
non-catalytic cascade/tandem sequences; and asymmetric metalcatalysis/organocatalysis 
approaches. From a synthetic point of view, construction of the fused-ring system of the 
indolo[2,3-a]quinolizidine alkaloids with control of the relative and absolute stereochemistry of 
the quinolizidine core represents a significant challenge that makes these natural products 
attractive synthetic targets. Traditionally, the majority of reported strategies for the asymmetric 
total synthesis of indolo[2,3-a]quinolizidine alkaloids have required a multistep synthesis that 
relies on starting materials from the chiral pool. These strategies often include several functional 
group transformations and tedious protection/deprotection steps, often providing a low overall 
yield of the target alkaloid. In the last decades cascade reactions have been applied in 
indoloquinolozidine alkaloids synthesis. Although extremely demanding, the well stablished 
advantages of these reactions include atom economy, as well as economies of time, labor, 
resources management, and waste generation. In this section we have include a significant 
racemic synthesis. Most recently there have been a few reports of efficient syntheses of 
optically active indoloquinolizidine natural products based on asymmetric catalysis. This 
approach is highly efficient and productive. However, the majority of the developed synthetic 
strategies is target-specific with respect to the relative configuration of the quinolizidine 
stereocenters and only allows for selective formation of one specific epimer of the alkaloid.  
 
2.1. Use of chiral pool resources 
Chiral pool synthesis makes use of chiral natural products by incorporating part of them into the 
target structure. As either enantiomer of the desired final product can be potentially generated, 
compounds from the chiral pool are extremely valuable and versatile in asymmetric synthesis. 
For many decades, it was the only source of enantiomerically pure compounds, but nowadays 
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many of the most effective chiral agents described in the literature have been designed and 
synthesized by organic chemists. 
 
2.1.1. Lactim ether route: Enantioselective synthesis of ()-dihydrocorynantheol (3) 
Prof. Tozo Fujii has published several papers on fused quinolizidine ring systems, including the 
total synthesis of ()-dihydrocorynantheine (1) in 1991.[42] The "lactim ether route" requires 
the coupling of the 3-(chloroacetyl)indole with the lactim ether 65, prepared from cincholoipon 
ethyl ester (64, obtainable from commercially available (+)-cinchonine (63) by the classical 
degradation procedure[43]). Subsequent treatment of the resulting keto derivative 66 with 
POC13 afforded the corresponding oxazolium chloride, which was then reduced by catalytic 
hydrogenation to furnish the lactam 67. The conversion into the tetracyclic ester 68 was carried 
out in 91% overall yield by means of Bischler-Napieralski cyclization followed by catalytic 
hydrogenation. Final LiAlH4-reduction of 68 afforded ()-dihydrocorynantheol (3) in 
quantitative yield (Scheme 1).  
 
Scheme 1  Enantioselective synthesis of ()-dihydrocorynantheol (3). 
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The usefulness of the "lactim ether route" in the asymmetric synthesis of Corynanthe-type 
indoloquinolizidine alkaloids is demonstrated by the application of this methodology to the 
synthesis of ()-ochromianine (73), ()-ophiorrhizine (74), and ()-ochropposinine (75), 
employing the lactim ether 65 as starting material (Scheme 2). 
 
 
Scheme 2  Enantioselective synthesis of of ()-ochromianine (73), ()-ophiorrhizine (74), and 
()-ochropposinine (75). 
 
2.1.2. Stereoselective Mannich reaction from a (R)-tryptophan derivative: Enantioselective 
synthesis of (+)-geissoschizine (76) 
A concise synthesis of (+)-geissoschizine (76) (Scheme 3), a biosynthetic precursor of a variety 
of monoterpenoid indole alkaloids,[1] from (R)-tryptophan was performed by Stephen F. Martin 
in 2003.[44] 
The synthesis started with a vinylogous Mannich reaction involving the iminium ion 78, which 
was prepared from (R)-tryptophan (77). The corresponding adduct was then treated directly with 
isobutylene in the presence of sulfuric acid to give 80 as the only isolable product. The 
nucleophilic attack of the vinyl ketene 79 on 78 occurred with high diastereoselectivity from the 
si face, establishing the correct absolute stereochemistry at C-3 of geissoschizine. Nb-Acylation 
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of 80 with diketene furnished an intermediate -keto amide that underwent facile cyclization via 
an intramolecular Michael reaction upon addition of potassium tert-butoxide to give 81. This 
reaction, which presumably proceeded under thermodynamic control to establish the correct 
relative stereochemistry at C-3 and C-5, completed the assembly of the corynantheane 
framework. 
Toward the introduction of the E-ethylidene side chain, hydride reduction of the C-19 carbonyl 
function in 81, followed by a stereoselective dehydration, led to the stereoselective elimination 
to give the ester 82. The subsequent selective reduction of the lactam function according to the 
Borch protocol[45] furnished 83 in 92% yield. Cleavage of the tert-butyl ester moiety was 
achieved using trifluoroacetic acid in the presence of thioanisole, as an essential cation 
scavenger. The cleavage of the carboxyl group at C-5 was accomplished by a radical 
decarbonylation of an acyl selenide intermediate. A final formylation by Winterfeldt's 
procedure[46] afforded (+)-geissoschizine (76) in 48% yield. 
 
Scheme 3  Enantioselective synthesis of (+)-geissoschizine (76). 
 
Three years later, this author described the total synthesis of the corynanthe alkaloid (±)-
dihydrocorynantheol (3) and the formal synthesis of (±)-hirsutine (4).[47] Two different 
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strategies for assembling the indoloquinolizidine system involving the use of the ring-closing 
metathesis for the construction of the piperidines D ring, followed by a 1,4-addition to introduce 
the requisite side chain at C-15, are the key steps of this new racemic approach (Scheme 4). 
 
Scheme 4  Total synthesis of the corynanthe alkaloid (±)-dihydrocorynantheol (3) and the 
formal synthesis of (±)-hirsutine (4). 
 
2.1.3. Pictet-Spengler cyclization from a (S)-tryptophanol-derived lactam: Asymmetric 
synthesis of both enantiomers of (+)-deplancheine (90) 
(+)-Deplancheine (90), an alkaloid with an unusual Corynantheine-type structure, was isolated 
from the New Caledonian plant Alstonia deplanchei. After its structure elucidation,[48] a 
number of total syntheses were reported for this alkaloid.[49-52]  
In 2005, Steven M. Allin,[51] reported the asymmetric synthesis of both enantiomers of the 
indole alkaloid deplancheine (Scheme 5) in an approach involving as the key intermediates the 
tryptophanol-derived lactams 93, which are easily accessible from (S)-tryptophanol (S-91) by a 
cyclocondensation process with the aldehyde-ester 92. Treatment of the mixture of bicyclic 
lactams with 2 M HCl in ethanol led to the formation of the indolo[2,3-a]quinolizine system by 
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Pictet-Spengler cyclization, affording 94 as a single compound. The hydroxymethyl chain 
underwent cleavage by oxidation to a carboxylic acid derivative through the corresponding 
aldehyde, followed by the generation of an acyl selenide and subsequent tin-mediated 
deacylation. The construction of the ethylidene moiety was achieved through a three-step 
procedure involving generation of the lithium enolate from 95 and a subsequent aldol reaction 
with acetaldehyde, activation of the hydroxyl group by mesylation, and finally, DBN-induced 
elimination to give the target 96. Deprotection of the indole nitrogen atom with TBAF, followed 
by the reduction of the lactam carbonyl group, as described by Martin and co-workers,[53] 
satisfactorily afforded ()-deplanchine (90).  
 
 
Scheme 5  Asymmetric synthesis of (+)-deplancheine [(+)-90]. 
 
To demonstrate the potential synthetic utility of the methodology, Allin and co-workers have 
also undertaken an asymmetric synthesis of the enantiomer of the natural product using (R)-
tryptophanol as the starting material (Scheme 6). 
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Scheme 6  Access to ()-deplancheine [()-90]. 
 
The stereochemical outcome of the Pictet Spengler cyclizations of tryptophanol-derived lactams 
was later thoroughly investigated by Amat-Bosch’s research group, describing the 
stereocontrolled generation of C-12b epimeric indolo[2,3-a]quinolizidine derivatives using the 
appropriated reactions conditions (Scheme 7).[54-56]  
 
Scheme 7  Stereocontrolled cyclizations from (S)-tryptophanol-derived oxazolopiperidone 
lactams. 
 
2.1.4. Modified Bischler-Napieralski reaction from a (S)-tryptophanol-derived lactam: 
Enantioselective formal synthesis of (+)-dihydrocorynantheine (1) and ()-
dihydrocorynantheol (3) 
Starting from an appropriately substituted tryptophanol-derived lactam bearing an ethyl 
substituent and an acetate chain at piperidine 3 and 4-positions,[54] respectively, an 
enantioselective access to indolo[2,3-a]quinolizidine alkaloids (+)-dihydrocorynantheine (1) 
and ()-dihydrocorynantheol (3) (Scheme 8) was developed by the Amat/Bosch research group 
in 2009.[57] The synthesis requires the cyclization at the indole 2-position to take place 
regioselectively from the lactam carbonyl moiety, which is accomplished using a modified 
Bischler-Napieralski reaction. 
The initial lactam 101 was prepared in 62% yield by cyclocondensation of (S)-tryptophanol (91) 
with racemic δ-oxo diester 100 in a process that involves a dynamic kinetic resolution and the 
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differentiation of diastereotopic ester chains, with generation of three stereogenic centers with a 
well-defined configuration in a single synthetic step. The regio- and stereoselective cyclization 
on the lactam carbonyl group, leading to an indolo[2,3-a]quinolizidine derivative, took place 
under modified Bischler-Napieralski conditions. Thus, alkylation of thiolactam (obtained by 
treatment of lactam 101 with Lawesson’s reagent) using benzyl bromide generated a 
(benzylsulfanyl)-substituted iminium ion, which can be considered as a sulphur analogue of a 
Bischeler-Napieralski chloro-substituted iminium salt. Sodium borohydride reduction of the 
iminium intermediate, arising from the subsequent cyclization on the indole 2-position, afforded 
pentacyclic compound 102 as a single isomer. The indole nitrogen was protected as an N-Boc 
derivative and the oxazolidine ring of the resulting pentacyclic compound was subjected to 
reductive ring-opening with borane to give 103. The synthesis of the target alkaloids was 
completed by cleavage of the hydroxymethyl appendage, which was satisfactorily accomplished 
by reductive decyanation of an -amino nitrile intermediate. Finally, deprotection of the indole 
nitrogen led to the tetracyclic ester 104,[58, 59] a known synthetic precursor of the alkaloids 
(+)-dihydrocorynantheine (1) and ()-dihydrocorynantheol (3). 
 
 
Scheme 8  Enantioselective formal synthesis of (+)-dihydrocorynantheine (1) and ()-
dihydrocorynantheol (3). 
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2.1.5. Access to 9-methoxyindole alkaloids: Total synthesis of 9-methoxygeissoschizol 
(105), 9-methoxy-Nb-methylgeissoschizol (106) and ()-mitragynine (32). 
Cook, in 2007, described an enantiospecific method for the synthesis of (R)-4-
methoxytryptophan (107) via a regiospecific Larock heteroannulation. This was a key reaction 
for the total synthesis of 9-methoxygeissoschizol (105), 9-metroxy-Nb-methylgeissoschizol 
(106), and mitragynine (32) using a asymmetric Pictet-Spengler strategy (Scheme 9).[60]  
 
Figure 13   Chemical structure of 9-methoxygeissoschizol (105), 9-methoxy-Nb-
methylgeissoschizol (106) and ()-mitragynine (32). 
 
Before Cook’s synthesis, the preparation of these alkaloids was hampered by the unavailability 
of 4-methoxytryptophan (107), which could only be obtained in high optical purity using the 
enzymatic kinetic resolution reported by Ley.[61, 62] The Larock heteroannulation,[63, 64] a 
palladium-catalysed heteroannulation reaction of substituted o-iodoanilines with internal 
alkynes, is a powerful method for the synthesis of substituted indole derivatives and has been 
satisfactorily employed for the regiospecific synthesis of both 11- and 12-methoxy-substituted 
indole alkaloids.[65-68] The strength of the Larock process stems from the regioselectivity that 
can be achieved when a bulky silyl-substituted alkyne is employed as a substrate. The internal 
alkyne chosen in this example (109) can be easily prepared by alkylation of Schöllkopf’s 
auxiliary, which in turn is available from L-valine.[69, 70] The heteroannulation between 2-
iodo-3-methoxy-N-Boc-aniline 108 and TMS-alkyne 109 gave 4-methoxy-Na-H indole 110 in 
82% yield. The subsequent hydrolysis of the Schöllkopf chiral auxiliary was accomplished by 
concomitant loss of the silyl group of 110, providing 4-methoxy-D-tryptophan ethyl ester 111 in 
a single step in 91% yield (Scheme 9). 
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Scheme 9  Preparation of the 4-methoxy-D-tryptophan ethyl ester 111. 
 
The monoalkylation of benzyl ester 112, obtained by hydrolysis and esterification of 111, with 
the allylic bromide 113 afforded the secondary amine 114 in 85% yield. The enantioselective 
construction of the stereocenter at C-3 was achieved by a modified asymmetric Pictet-Spengler 
reaction between 114 and the aldehyde 115 to furnish the tetrahydro--carboline system. The 
,-unsaturated ester moiety was generated via standard transformations, including removal of 
1 equivalent of thiophenol, followed by an oxidation and sulfoxide elimination sequence, 
affording compound 116. The ,-unsaturated ester 116 was then subjected to the Ni-(COD)2-
mediated cyclization to provide the desired Corynanthe skeleton 117 in 75% yield. Removal of 
the benzyl group was achieved when 117 was treated with PdCl2 in the presence of Et3SiH and 
TEA, and the corresponding carboxylic acid was converted into tetracyclic ester 118 via the 
Barton-Crich decarboxylation process (Scheme 10).  
Scheme 10  Synthesis of the key intermediate 118. 
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The ester 118 was envisaged as an advanced precursor for the synthesis of three 9-methoxy-
substituted indole alkaloids. Thus, the ester carbonyl moiety present in 118 was reduced with 
LiAlH4 to give 9-methoxygeissoschizol (105) in 90% yield, and 9-methoxy-Nb-
methylgeissoschizol (106) was then synthesized via Nb methylation with methyl iodide, 
followed by an iodide exchange using AgCl. To prepare mitraginine (32), reduction of the 
olefin bond in 118 was required. The reduction of this double bond with Crabtree’s catalyst, 
followed by treatment with (Boc)2O in the presence of a catalytic amount of DMAP, provided 
the Boc derivative 119 in 64% overall yield. The ester 119 was then subjected to formylation 
and Boc deprotection. The final acetal formation and t-BuOK-mediated elimination of MeOH, 
analogous to the final steps reported by Takayama,[71] provided ()-mitragynine (32) (Scheme 
11). 
 
Scheme 11  Total synthesis of 9-methoxygeissoschizol (105), 9-methoxy-Nb-
methylgeissoschizol (106) and ()-mitragynine (32). 
 
Starting from (R)-tryptophan [(R)-91] as a chiral pool reagent, this methodology allows the 
enantiospecific total synthesis of ()-corynantheidine (14), ()-corynantheidol (122), ()-
geissoschizol (123), and (+)-geissoschizine (76) via the common key intermediate 119 (Scheme 
12).[72] For the construction of the all-D-ring system present in corynantheidol and 
corynantheine, an intramolecular Heck coupling of ,-unsaturated ester 119 and subsequent 
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NaBH4-reduction in presence of a catalytic amount of NiCl2·6H2O was performed. In turn, to 
construct the molecular framework of geissoschizol and geissoschizine from 119, a 
stereoselective Michael reaction consecutively using Ni[COD]2-Et3N and Et3SiH was employed. 
 
 
Scheme 12 - Enantiospecific total synthesis of ()-corynantheidine (14), ()-corynantheidol 
(122), ()-geissoschizol (123), and (+)-geissoschizine (76). 
 
2.1.6 Regioselective reduction of an imide carbonyl followed by an intramolecular 
stereoselective cyclization: Enantioselective formal synthesis of ()-deplancheine (90). 
The enantioselective formal synthesis of ()-deplancheine (90), in a 9-step sequence from 
glutamic acid in good overall yields and high enantiomeric purity, was recently reported by 
Argade (Scheme 13).[52]  
A carbodiimide-induced coupling reaction of Boc-protected tryptamine 124 with 
enantiomerically pure (S)-tetrahydro-5-oxo-2-furancarboxylic acid (125), prepared from (S)-
glutamic acid furnished amidolactone 126 in 86% yield and 96% enantiomeric purity. 
Subsequent treatment with t-BuOK afforded the base-catalysed rearrangement of 126 to the 
hydroxyglutarimide 127 in 65% yield. The hydroxyl group in compound 127 was then 
transformed to the corresponding acetate using acetic anhydride and triethylamine. The 
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regioselective sodium borohydride reduction of the more reactive imide carbonyl group, 
followed by chemoselective trifluoroacetic acid-induced intramolecular cyclization, afforded 
indoloquinolicidine derivative 128 as a 23:2 mixture of isomers in very good yield. The 
diastereoisomers 128a/b were quantitatively separated by flash column chromatography and the 
major isomer (128a) was treated with K2CO3/MeOH to undergo one-pot deacylation and N-
Boc-deprotection to provide 129 in 92% yield. Subsequent chemoselective reaction with an 
excess of phenyl chlorothionoformate in the presence of diisopropylethylamine provided a 
xanthate intermediate, which was submitted to Barton−McCombie deoxygenation using 
tributyltin hydride in the presence of AIBN. The resulting lactam 130 was obtained in 54% 
yield and 94% ee (by HPLC) and it was transformed in ()-deplancheine in a seven-step 
synthetic sequence.[51]  
 
Scheme 13  Enantioselective formal synthesis of ()-deplancheine. 
 
2.2. Non-catalytic cascade/tandem sequences 
Cascade reactions have received considerable attention within organic chemistry, as reflected by 
the high number of reviews covering this field.[73-75] A variety of terms, including "cascade", 
"domino", "tandem" and "sequential", are used in the literature, often apparently 
interchangeably, although efforts have been made to restore order to this area of reaction 
terminology.[76] Nevertheless, we shall maintain the term used by each author in the original 
publication. This type of reaction in structurally complex molecule synthesis has several 
intrinsic advantages: multiple bond formation, time and cost efficiency, atom economy, 
38 
 
environmental sustainability as well as applicability to diversity-oriented high-throughput 
synthesis. Since the synthetic effort toward natural products and other interesting compounds 
usually requires the introduction of several stereogenic centers, the design of cascades to 
provide specific targeted molecules of structural and stereochemical complexity constitutes a 
significant intellectual challenge.  
 
2.2.1 Stereoselective addition of a chiral -sulfinyl ketamine anion to methyl acrylate: 
Asymmetric synthesis of 1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizidine (131). 
One of the first examples of enantioselective synthesis of indoloquinolizidine alkaloids using a 
tandem reaction was reported by Hua in 1991, and it was based on the asymmetric 1,4-
addition/ring-closure procedure (Scheme 14).[77] 
The chiral sulfinyl ketimine 134 was prepared from harmalan (132) and ()-menthyl p-
toluenesulfinate (133), and subsequently used in the stereoselective conjugate addition with 
methyl acrylate, followed by in situ cyclization. The resulting lactam 135, formed in 77% yield, 
was then submitted to NaCNBH3-reduction of the double bond. In contrast with previous results 
of this author, the reduction in this case was not stereoselective and a 1.9:1 mixture of 
diastereomers was formed. After separation in column chromatography, desulfuration of 136b 
with Raney Nickel, followed by reduction with LiAlH4, afforded 1,2,3,4,6,7,12,12b-
octahydroindolo[2,3-a]quinolizidine (131). 
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Scheme 14  Asymmetric synthesis of 1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizidine 
(131). 
 
2.2.2 A domino Knoevenagel-hetero-Diels-Alder reaction strategy: Enantioselective total 
synthesis of (+)-hirsutine (4) and (+)-dihydrocorynantheine (1) 
The enantioselective synthesis of corynanthe indole alkaloids (+)-hirsutine (4) and (+)-
dihydrocorynantheine (1) by a domino Knoevenagel-hetero-Diels-Alder reaction, using 
enantiomerically pure tetrahydro--carboline carbaldehydes as starting material, was described 
in 1999 by Tietze.[78]  
Aldehydes 140 (Nind-Boc) and 141 (Nind-H) were prepared on a large scale by separation of the 
diastereomeric amides 138, which were prepared from rac-137 and ()-camphanic acid as 
shown in scheme 15. 
 
Scheme 15  Preparation of chiral non-racemic tetrahydro--carboline carbaldehydes 140 and 
141. 
 
Condensation of the aldehyde 140 with Meldrum’s acid (142) and 4-methoxybenzyl butenyl 
ether 143, in an ultrasonic bath and in the presence of ethylenediamine diacetate (EDDA), led to 
cycloadduct 145 in 84% yield and with an asymmetric induction greater than 20:1. Direct 
solvolysis without further purification, followed by hydrogenation, afforded the tetracycle 148a 
in 67% yield as a single product. 
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Similarly, the domino Knoevenagel-hetero-Diels-Alder reaction of 141 with 142 and the enol 
ether 144 gave the diastereomeric cycloadducts 146 in very good yield, although with somewhat 
lower asymmetric induction of 4.8:1. The mixture of cycloadducts was converted into the tert-
butoxycarbonyl derivatives 147, which were then treated with methanol/K2CO3 and 
hydrogenated. Chromatographic separation gave the enantiomerically pure diastereomer 148b in 
62% overall yield from 147. Cleavage of the tert-butoxycarbonyl group in 148a and 148b, 
followed by condensation with methyl formate and treatment with diazomethane by known 
procedures,[71] gave the desired enantiomerically pure indole alkaloids (+)-hirsutine (4) and 
(+)-dihydrocorynantheine (1) (Scheme 16).  
 
Scheme 16  Enantioselective total synthesis of (+)-hirsutine (4) and (+)-dihydrocorynantheine 
(1). 
 
2.2.3 Tandem retro-aldol-Pictet-Spengler: Total synthesis of ()-dihydrocorynantheol (3) 
The diastereocontrolled synthesis of the ()-dihydrocorynantheol (3) alkaloid was accomplished 
by Ogasawara and Iwabuchi[79] employing a cascade sequence consisting of a BrØnsted-acid-
promoted retro-aldol reaction of the key intermediate 153 and a subsequent stereocontrolled 
Pictet-Spengler reaction. 
Amide 153 was prepared in 62% overall yield (Scheme 17) from the bicyclo[3.2.1]octenone 
chiral building block ()-149[80] in a four-step sequence involving the regioselective and 
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convex-face selective introduction of a nitromethyl group, ketalization under Noyori’s 
conditions,[81] reduction of the nitro group to the primary amine, and condensation with indole-
3-acetic acid (152). 
 
 
Scheme 17  Preparation of the key intermediate 153. 
 
The treatment of amide 153 with methanesulfonic acid in boiling dioxane afforded a yohimbine-
type derivative 154a in 52% yield, together with pseudoyohimbane (154b) in 23% yield, by a 
tandem retro-aldol-Pictet-Spengler reaction and C-3 epimerization. The recovered 154b was 
subjected to the above-mentioned acidic conditions to obtain 154a in 59% yield and unreacted 
154b in 29% yield. For the transformation of the E-ring moiety to the seco form present in the 
dihydrocorynantheol (3) alkaloid, the ketal moiety was deprotected, and the resulting ketone 
was reacted with pyrrolidine to form an enamine, which was immediately treated with 
trimethylene dithiotosylate to generate 155. Upon exposure to potassium hydroxide in boiling 
tert-butyl alcohol, the dithioketone moiety was cleaved and the resulting acid was esterified to 
obtain methyl ester 156. Treatment of this compound with iodomethane in aqueous acetonitrile, 
followed by the reduction of the resulting aldehyde with sodium borohydride, afforded the 
corresponding alcohol, which was protected as TBS ether to give compound 157. After 
subsequent treatment with lithium aluminium hydride and mesylation, the resulting mesylate 
was subjected to reduction using LiAlH4 in boiling dioxane to furnish, with the concomitant 
reduction of the amide moiety, as well as deprotection of the TBS group, completed the 
synthesis of the target alkaloid (–)-dihydrocorynantheol (3) (Scheme 18).  
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Scheme 18  Total synthesis of ()-dihydrocorynantheol (3). 
 
2.2.4. One-pot asymmetric azaelectrocyclization: Enantioselective synthesis of (–)-
corynantheidol (122) and formal synthesis of (–)-corynantheidine (14). 
Soon after the publication of the one-pot asymmetric azaelectrocyclization procedure for the 
synthesis of chiral 2,4,5-trisubstituted tetrahydropyridines,[82] Katsumura demonstrated the 
usefulness of his methodology with an enantioselective synthesis of the indole alkaloids ()-
corynantheidol (122) and (–)-corynantheidine (14).[83]  
The one-pot azaelectrocyclization requires an initial mixture of the tetrasubstituted vinyl iodide 
158 and the aminoindanol derivative 159, and the subsequent addition of indolyl vinyl stannane 
160, and catalytic amounts of Pd2(dba)3, trifurylphosphine and LiCl. Four new bonds and three 
stereocenters were generated in a single operation, affording aminoacetal 161 as a single 
diastereomer in 77% yield (Scheme 19).  
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Scheme 19  Preparation of the chiral non-racemic piperidine 161. 
 
The reduction of the ester group and aminoacetal moiety with DIBAL-H, followed by 
conversion of the resulting alcohol into a carbonate moiety, allowed the one-carbon elongation 
at the four position of the tetrahydropiridine ring by CO insertion, affording the ester 163. 
Elimination of the indanol chiral auxiliary was accomplished by oxidation with lead tetraacetate 
in the presence of n-propylamine, leading to the corresponding secondary amine. The tetracyclic 
ring system was constructed from the amine intermediate by Bosch’s Pummerer cyclization 
sequence,[84] via the generation of sulfoxide intermediate 164 and subsequent cyclization with 
trimethylsilyl triflate in the presence of diisopropylethylamine. The removal of the resulting 
thiophenyl substituent and the phenylsulfonyl group at the indole nitrogen in 165 was carried 
out using the Birch reduction, and the stereoselective reduction of the double bond in the 
tetrahydropyridine ring was accomplished by hydrogenation with platinum dioxide, affording 
()-corynantheidol (122) (Scheme 20).  
The formal synthesis of ()-corynantheidine (14) from the intermediate 165 was achieved by 
Ba(OH)2 hydrolysis of the ester moiety to afford carboxylic acid 166. The subsequent Birch 
reduction to remove the thiophenyl and benzenesulfonyl groups, esterification, and catalytic 
hydrogenation provided Cook’s intermediate 167, from which the synthesis of ()-
corynantheidine (14) could be completed in two steps (Scheme 20).[72] 
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Scheme 20  Enantioselective synthesis of (–)-corynantheidol (122) and formal synthesis of (–)-
corynantheidine (14). 
 
2.2.5 Stereodivergent synthesis of (±)-geissoschizol (123), (±)-corynantheidol (122), (±)-
dihydrocorynantheol (3) from a single synthetic intermediate. 
Traditionally, indoloquinolizidine alkaloids have been approached by individual strategies that 
have given access to a small number of structurally similar synthetic targets. In 2010, Robert M. 
Williams envisioned a approach based on a large-scale synthesis of a functionalized lactone 
intermediate 171, via a tandem Michael cyclization and Horner-Wadsworth-Emmons 
olefination, which can be rapidly modified to obtain different alkaloids of this group, as well as 
secologanin dopamine alkaloids.[85]  
Assembly of lactone 171 (Scheme 21) [86] begins with the condensation of aldehyde 168 with 
commercially available trimethyl acetophosphonate under Masamune-Roush conditions, 
affording the unsaturated ester 169 as a single isomer in good yield. Deprotection and 
subsequent esterification gave the desired substrate 170, which upon treatment with Cs2CO3 and 
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acetaldehyde underwent sequential intramolecular Michael cyclization and HWE-olefination to 
yield lactone 171 as a 1.6:1 mixture of E/Z isomers.  
 
Scheme 21  Preparation of the intermediate 171. 
 
Reduction of the lactone carbonyl of 171 with DIBAL-H, followed by a one-step reductive 
amination/lactam cyclization with tryptamine, afforded lactam intermediate 172. Protection of 
the hydroxyl functionality as an acetate ester, followed by Bischler-Napieralski cyclization, 
gave acetate 173, which was deprotected to yield (±)-geissoschizol in good yield (Scheme 22). 
Alternatively, catalytic hydrogenation of the olefin of lactone 171 exclusively generates the 
corresponding cis- lactone 174a, presumably due to the delivery of hydrogen to the least 
sterically hindered face of the olefin. Conversely, conjugate reduction leads solely to the 
thermodynamically favored trans-isomer of the disubstituted lactone 174b. Following a 
sequence similar to the above, corynantheidol and dihydrocorynantheol (3) were obtained from 
lactones 174a and 174b, respectively (Scheme 22). However, pure lactone 174b led to a 1.3:1 
mixture of isomers, which were separated by column chromatography after the formation of the 
indoloquinolizidine system.  
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Scheme 22  Stereodivergent synthesis of (±)-geisssoschizol (123), (±)-corynantheidol (122), 
(±)-dihydrocorynantheol (3). 
 
2.3. Asymmetric metalcatalysis/organocatalysis approaches 
Catalysis has grown to play a prominent role in chemistry as it enables compounds to be 
prepared efficiently with atom economy. As well as producing far less waste is produced, new 
selective catalytic processes facilitate short-cuts in total synthesis. In recent years, asymmetric 
syntheses using organic compounds as catalysts have attracted considerable attention [87] as 
they are environmentally friendly compared with conventional transition metal catalysts. 
However, although this area is under intense study, there are still few reports [88, 89] on the 
application of this methodology for asymmetric total synthesis of natural products. 
 
2.3.1 Asymmetric hydrogen-transfer reaction: Enantioselective Total synthesis of (+)-
arborescidine A 
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A short enantiocontrolled syntheses of (+)-arborescidine A (13), by taking advantage of the 
Noyori asymmetric hydrogen-transfer reaction of appropriately functionalized -carboline 
derivative, was described by Rawal in 2004 (Scheme 23).[90] 
The 6-bromotryptamine (178), which was prepared from 6-bromoindole (177) following the 
Shumaker and Davidson method,[91] reacted with glutamic anhydride affording the 
corresponding amide carboxylic acid, which was then esterificated. Subsequent treatment with 
POCl3 promoted the Bischler-Napieralsky cyclization to produce imine 180 in 86% yield. The 
Noyori reduction[92, 93] of imine 180, to set the required asymmetry, was accomplished with 
preformed (S,S)-TsDPEN-Ru(II) complex, which afforded, after in situ cyclization, lactam 181 
in 89% yield and 96% ee. Finally, alane reduction of the lactam carbonyl afforded (+)-
arborescidine A (13).  
 
Scheme 23  Enantioselective total synthesis of (+)-arborescidine A (13). 
 
2.3.2 A Stereodivergent Strategy for the Preparation of Corynantheine alkaloids 
A general and excellent catalytic asymmetric strategy for the total and formal synthesis of a 
broad number of optically active natural products from the corynantheine and ipecac alkaloid 
families, have been described by Franzén in 2011.[94] The construction of the core alkaloid 
skeletons, with the correct absolute and relative stereochemistry, relies on an enantioselective 
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and diastereodivergent one-pot cascade sequence followed by an additional diastereodivergent 
reaction step. Starting from common and easily accessible starting materials and using a 
common synthetic route this approach gives access to the total synthesis of the indolo[2,3-
a]quinolizidine alkaloids ()-dihydrocorynantheol (3), (+)-hirsutinol (182), ()-corynantheol 
(183), ()-dihydrocorynantheal (184), and ()-corynantheal (185). 
The one-pot stereoselective construction of the quinolizidine carbon skeleton required the ,-
unsaturated aldehyde 186, which was easily accessible through the cross-metathesis of acroleine 
and 3-butenol, and the -ketoamides 187 which was obtained through the condensation of tert-
butyl acetoacetate with the corresponding 2-arylethanamine. In the presence of catalyst 188, -
ketoamides 187 smoothly reacted with the ,-unsaturated aldehyde to give a diastereomeric 
mixture of lactols intermediates and then the reaction was quenched by addition of 
trifluoroacetic acid (TFA) giving a 1:1 mixture of the two ring-junction isomers -189 and -
189, which could be isolated in good yields and high enantioselectivity in a two-step one-pot 
process. Interestingly, when the reaction was quenched with acetyl chloride resulted in the 
formation of the thermodynamically favored indolo[2,3-a]quinolizidine -189 as the only 
observable isomer, whereas when using benzoyl chloride, a switch in diastereoselectivity it 
happened and the kinetically favored product -189 was obtained as the major isomer in 82:18 
diastereoselectivity. It is also worth noting that the kinetically favored -indolo[2,3-
a]quinolizidine -189 could be epimerized to the thermodynamically favored -189 epimer by 
treatment with TFA heated at reflux to give a ratio of 85:15 in favor of the -epimer. 
Subsequent reduction of the crude reaction mixture from the one-pot cascade was accomplished 
by initial alkylation with triethyloxonium tetrafluoroborate, followed by NaBH4-reduction to 
give the corresponding amines 190 in high to moderate overall yields, and at this stage, the - 
and -epimers could be easily separated by flash column (Scheme 24). 
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Scheme 24  Preparation of the - and -epimers of the amine 190. 
 
Subsequent treatment of the -epimer -190 with HCl in water/THF at room temperature gave 
exclusively the trans ring junction of the corresponding lactol -trans-191. The selective 
formation of this stereocenter is due to the thermodynamic stability of the all-equatorial 
quinolizidine structure, and attempts to access the -cis configuration have failed. However, in 
the -series treatment of indolo[2,3-a]quinolizidine with HCl in water/THF at room temperature 
gave a 4:1 mixture of -cis-191 and -trans-191. Interestingly, lactol formation at elevated 
temperatures (HCl in water/THF at 65 ºC) reversed the selectivity and -trans-191 was formed 
with a 5:1 diastereomeric ratio. The resulting lactols were successively treated with acetic 
anhydride to promote the ring opening of the lactol, and with tosyl hydrazide to give the 
corresponding hydrazones 192, which were isolated as a single isomer in good to excellent 
overall yields from amine 190 without purification of synthetic intermediates (Scheme 25). 
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Scheme 25  Preparation of the hydrazones 192. 
 
Hydrazones 12b--trans-192 and 12b--trans-192 were reduced with NaBH3CN in the 
presence of HCl. Final addition of KOH aq. in methanol gave the natural product ()-
dihydrocorynantheol (3) and (+)-hirsutinol (182). On the other hand, treatment of hydrazones -
trans-192 and -trans-192 with n-BuLi resulted in the elimination of the hydrazone and 
deacetylation providing access to ()-corynantheol (183), whereas the oxidation of the 
hydroxyquinolizidines gave ()-dihydrocorynantheal (184) and ()-corynantheal (185) (Scheme 
26). 
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Scheme 26  Preparation of Corynantheine alkaloids. 
 
2.3.3. Organocatalytic Enantioselective total synthesis of ()-arboricine (28). 
A concise and scalable synthesis of ()-arboricine (28) based on an asymmetric organocatalytic 
Pictet-Spengler reaction, followed by a Pd(0)-catalyzed enolate cyclization, was described by 
Maarseveen and Hiemstra in 2009 (Scheme 27).[95] 
The synthesis started with the know tryptamine 194,[96] which was prepared in one step by 
alkylation of tryptamine with Z-2-iodo-2-butene-1-ol mesylate (193) in 84% yield. Pictet-
Spengler condensation of 194 with the dioxolane 195 using catalyst (R)-binol-PA (A), provided 
196 in 92% yield and 78% ee. The acetal protecting group improves the ee of this reaction. The 
best ee was obtained using the sterically slightly more demanding catalyst (R)-H8-binol-PA (B) 
that gave 196 in 86% yield and 89% ee. Treatment of 196 with Boc2O and DMAP followed by 
diluted HCl in acetone gave ketone 197 in 96% overall yield. The closure of the piperidine ring 
was accomplished by a Pd(0)-catalyzed vinyl iodide-enolate coupling using the procedure 
published by Sole and Bonjoch, in which potassium phenoxide avoids the migration of the 
isolated exocyclic double bond[97] affording keto amine 198 as a single diastereoisomer. A 
52 
 
single recrystallization from the EtOAc/PE mixture gave enantiometically pure 198. ()-
arboricine was obtained in 81% yield after TFA-mediated removal of the Boc-protecting group 
of 198. 
 
Scheme 27  Organocatalytic enantioselective total synthesis of ()-arboricine (28). 
 
2.3.4. Proline-catalyzed asymmetric addition reaction: Total synthesis of ent-
dihydrocorynantheol (3) 
In the context of Itoh’s research on the synthesis of chiral 1-substituted 1,2,3,4-tetrahydro--
carboline derivatives, using the asymmetric addition of methyl ketones to the -carboline 
system in the presence of (S)-proline,[98] this author envisaged that 3-ethyl-3-buten-2-one as a 
good substrate for the concise asymmetric synthesis of ent-dihydrocorynantheol (Scheme 
28).[99]  
The reaction of N-tosyl-3,4-dihydro--carboline (199) with 3-ethyl-3-buten-2-one (200)[100] in 
the presence of (S)-proline (201) led to the formation of the D ring of the target molecule with 
the correct configuration in a single step, affording the product 202 in a good yield of 85% with 
99% ee. Since there were no intermediates observed in the reaction, it was not possible to 
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conclude whether the reaction proceeded via Mannich-Michael reaction or a Diels-Alder-type 
addition. Alkene 203 was then quantitatively obtained in the ratio of E/Z 1:20 from compound 
202 by Wittig reaction. Subsequent treatment with Red-Al brought about the reductive 
elimination of the tosyl group and the reduction of the ester group to an alcohol. A final 
hydrogenation satisfactorily afforded ent-dihydrocorynantheol. 
 
Scheme 28  Total synthesis of ent-dihydrocorynantheol (ent-3). 
 
Final Remarks 
There has been much progress in the synthesis and biological evaluation of tetracyclic indole 
alkaloids containing an indolo[2,3-a]quinolizidine system. However, we can still find many 
reports describing the biological activity of extracts, instead of describing the activity of the 
pure indole alkaloids. Also, many reports do not describe correctly the stereochemistry of the 
indole alkaloids isolated and/or evaluated.  
Herein, we have made a review about the potential pharmacological applications of indolo[2,3-
a]quinolizidines and derivatives (see Table 1), as well as about the most important asymmetric 
approaches developed for the construction of the indolo[2,3-a]quinolizine ring system. 
Although, to our knowledge, there are no alkaloids in the market or in clinical assays containing 
an indolo[2,3-a]quinolizidine system, compounds containing a tetracyclic indole[2,3-a]-
quinolizidine scaffold seem to be a potential starting point for the development of effective 
drugs.  
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